| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-11 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.27 | 4e-11 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.25 | 6e-11 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-10 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-10 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-09 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-09 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-09 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |